Chartwell Investment Partners, LLC Xencor Inc Transaction History

Chartwell Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 11, 2019	SELL	$27.85 - $38.09 $1.14 Million - $1.55 Million	-40,778 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$32.39 - $42.05 $40,940 - $53,151	1,264 Added 3.2%	40,778 $1.48 Million
Q3 2018 Nov 08, 2018	BUY	$35.69 - $47.65 $1,998 - $2,668	56 Added 0.14%	39,514 $1.54 Million
Q2 2018 Aug 09, 2018	BUY	$28.41 - $42.41 $1.12 Million - $1.67 Million	39,458 New	39,458 $1.46 Million
Q1 2018 May 08, 2018	SELL	$21.18 - $33.78 $868,909 - $1.39 Million	-41,025 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$21.18 - $33.78 $868,909 - $1.39 Million	41,025 New	41,025 $1.23 Million

199

73.7M

1.7K

4.2K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $788M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.